Cargando…
Norovirus Protease Structure and Antivirals Development
Human norovirus (HuNoV) infection is a global health and economic burden. Currently, there are no licensed HuNoV vaccines or antiviral drugs available. The protease encoded by the HuNoV genome plays a critical role in virus replication by cleaving the polyprotein and is an excellent target for devel...
Autores principales: | Zhao, Boyang, Hu, Liya, Song, Yongcheng, Patil, Ketki, Ramani, Sasirekha, Atmar, Robert L., Estes, Mary K., Prasad, B. V. Venkataram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537771/ https://www.ncbi.nlm.nih.gov/pubmed/34696498 http://dx.doi.org/10.3390/v13102069 |
Ejemplares similares
-
Glycan Recognition in Human Norovirus Infections
por: Tenge, Victoria R., et al.
Publicado: (2021) -
A Standardized Antiviral Pipeline for Human Norovirus in Human Intestinal Enteroids Demonstrates No Antiviral Activity of Nitazoxanide
por: Lewis, Miranda A., et al.
Publicado: (2023) -
2650. Evaluating Antiviral Agents for Human Noroviruses Using a Human Intestinal Enteroid Model
por: Cortes-Penfield, Nicolas W, et al.
Publicado: (2019) -
Correlates of Protection against Norovirus Infection and Disease—Where Are We Now, Where Do We Go?
por: Ramani, Sasirekha, et al.
Publicado: (2016) -
Norovirus in Cancer Patients: A Review
por: Kondapi, Divya Samantha, et al.
Publicado: (2021)